Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Debt (2020)

Caribou Biosciences (CRBU) has disclosed Non-Current Debt for 1 consecutive years, with $924000.0 as the latest value for Q4 2020.

  • Quarterly Non-Current Debt changed N/A to $924000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $924000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at $924000.0 for FY2020, N/A changed from the prior year.
  • Non-Current Debt for Q4 2020 was $924000.0 at Caribou Biosciences.
  • The five-year high for Non-Current Debt was $924000.0 in Q4 2020, with the low at $924000.0 in Q4 2020.